12 /100
LOW RISK
Score updated Jul 14, 2026

BNS — The Bank of Nova Scotia Dilution Risk Tracker

Track BNS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BNS — Get alerts when the score changes →

As of July 14, 2026, The Bank of Nova Scotia (BNS) has a DilutionWatch DilutionScore of 12/100, rated LOW dilution risk. The Bank of Nova Scotia has a market capitalization of $98.15B, 1.24B shares outstanding, 51 institutional holders tracked.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
10
📊 Float Risk
0
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BNS.
🔔 Track BNS — Get forecast alerts →

💹 Market Data

Market Cap$98.15B
Shares Outstanding1.24B
Float1.21B
Cash$385.04B
Debt$253.65B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 11.0% shares (2026Q1 vs prior)
51 institutional holders · 23.37M shares
#1 Magnetar Financial LLC 1.98M shares
#2 AQR Arbitrage LLC 1.49M shares
#3 GOLDMAN SACHS GROUP INC 1.43M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest8.05M
Days to Cover2.5
% of Float0.7%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

424B3 DEBT Apr 30, 2026
4 INSIDER TRANSACTION Apr 29, 2026
4 INSIDER TRANSACTION Apr 22, 2026
424B3 DEBT Apr 06, 2026
4 INSIDER TRANSACTION Mar 03, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for BNS Shareholders

The Bank of Nova Scotia (BNS) has a DilutionScore of 12/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for BNS shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for BNS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for BNS alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track BNS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BNS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BNS
📊 BNS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BNS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.